Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 704207, 9 pages
http://dx.doi.org/10.1155/2014/704207
Research Article

Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

1Institute of Public Health, Catholic University of the Sacred Heart, 00168 Rome, Italy
2Department of Public Health, University of Turin, 10126 Turin, Italy
3Rheumatology Department, Padua Hospital, 35128 Padua, Italy
4Institute of Management, Scuola Superiore Sant’Anna, 56127 Pisa, Italy
5GSK, 37135 Verona, Italy
6Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy

Received 2 May 2014; Accepted 29 June 2014; Published 17 August 2014

Academic Editor: Norberto Ortego-Centeno

Copyright © 2014 Maria Lucia Specchia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Maria Lucia Specchia, Chiara de Waure, Maria Rosaria Gualano, et al., “Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus,” BioMed Research International, vol. 2014, Article ID 704207, 9 pages, 2014. https://doi.org/10.1155/2014/704207.